Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 22 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

9%

2 trials in Phase 3/4

Results Transparency

13%

1 of 8 completed with results

Key Signals

1 with results100% success

Data Visualizations

Phase Distribution

15Total
Not Applicable (4)
P 1 (3)
P 2 (6)
P 3 (2)

Trial Status

Completed8
Unknown6
Recruiting4
Withdrawn3
Active Not Recruiting1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 8 completed trials

Clinical Trials (22)

Showing 20 of 20 trials
NCT04716946Phase 2Active Not Recruiting

Treating Early-stage Non-Small Cell Lung Cancer With Durvalumab and Radiation Therapy

NCT07323732Phase 2Recruiting

A Study of BIO 300 and Thoracic Radiation Therapy in People With Non-Small Cell Lung Cancer and Interstitial Lung Disease

NCT04585477Phase 2Recruiting

Adjuvant ctDNA-Adapted Personalized Treatment in Early Stage NSCLC (ADAPT-E)

NCT07250360CompletedPrimary

Adjuvant Chemotherapy for High-Risk Pathologic Stage I Non-Squamous NSCLC

NCT03603002Not ApplicableCompletedPrimary

Pathologic and Immunologic Response After Ablative Radiation in Lung Cancer

NCT03383302Phase 1Completed

SBRT With Immunotherapy in Early Stage Non-small Cell Lung Cancer: Tolerability and Lung Effects

NCT02622581Recruiting

Clinical Research Platform Into Molecular Testing, Treatment and Outcome of (Non-)Small Cell Lung Carcinoma Patients

NCT03172156CompletedPrimary

ctDNA Dynamic Monitoring and Its Role of Prognosis in Stage I NSCLS by NGS

NCT04944173Phase 2Withdrawn

SCION: SABR and Checkpoint Inhibition of NSCLC

NCT06341387Unknown

Volatolomic and Proteomic Profile for Early Diagnosis of Lung Cancer

NCT04271384Phase 2CompletedPrimary

Stereotactic Ablative Radiotherapy With Nivolumab for Early-Stage Operable Non-Small Cell Lung Cancer

NCT06180239UnknownPrimary

Segmentectomy vs Lobectomy

NCT05451173Phase 1Unknown

Combining ICI With SBRT or HypoFrx-RT for ES NSCLC

NCT05453721Not ApplicableRecruiting

Effect and Long-Term Outcomes of Indocyanine Green Fluorescence Imaging Method Versus Modified Inflation-Deflation Method in Identification of Intersegmental Plane(IMPLANE-0529)

NCT03216551Completed

Mediastinal Staging Accuracy of a Selective Lymphadenectomy Strategy in Early Stage NSCLC (ECTOP-1003)

NCT04342377Phase 3Completed

The Canada Lymph Node Score Project: A Crossover Trial

NCT05097417Not ApplicableUnknownPrimary

Traditional Chinese Medicine Combined With Thermal and Cold Ablation for Early-stage Lung Cancer

NCT03431415Not ApplicableWithdrawnPrimary

Surgery Versus Stereotactic Body Radiation Therapy for Stage up to IA2 (T1a or T1b) Non-small Cell Lung Cancer

NCT01795521Phase 2UnknownPrimary

LungTech: Stereotactic Body Radiotherapy (SBRT) of Inoperable Centrally Located NSCLC

NCT03029871Phase 1WithdrawnPrimary

Oncolytic Adenovirus-Mediated Gene Therapy for Lung Cancer

Scroll to load more

Research Network

Activity Timeline